Peripheral nerve decompression plus nerve stimulation for painful diabetic neuropathy
Official title: Study on the Safety and Therapeutic Effect of Peripheral Nerve Decompression Combined With Peripheral Nerve Stimulation for the Treatment of Painful Diabetic Peripheral Neuropathy
Run by Qilu Hospital of Shandong University · NCT07911410 · Data updated 2026-11-12
This study looks at whether combining nerve decompression with nerve stimulation can help reduce pain in people with painful diabetic neuropathy.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Qilu Hospital of Shandong University Academic / other |
| Locations | 4 sites (Jinan, Shandong and 3 other locations) |
| Status | Recruiting |
| Started | October 15, 2026 |
| Main results expected | April 30, 2027 |
| Study ends | May 31, 2027 |
| Registry record updated | November 2, 2026 |
| Trial ID | NCT07911410 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with diagnosed painful diabetic peripheral neuropathy who had a first-time lower-extremity peripheral nerve decompression plus peripheral nerve stimulation and have complete electronic medical records.
✕Probably not a fit
Patients with non-painful or predominantly non-neuropathic symptoms, those with prior decompression surgery, or those with significant comorbidities may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational analysis gathers patients with diabetic peripheral neuropathy who underwent lower-extremity peripheral nerve decompression combined with peripheral nerve stimulation. It involves multi-center data from four Chinese hospitals collected between January 2025 and May 2026. The aim is to document safety and potential pain relief, as well as the impact on numbness and function, in a real-world setting. The study builds on the idea that nerve compression contributes to symptoms and explores whether a combined surgical and neuromodulation approach offers benefits beyond standard pharmacologic therapy. No interventional randomization is described in this observational design.
Why it matters
Potential benefit: If successful, patients may experience reduced pain and improved nerve-related symptoms with a procedure that targets both compression and nerve signaling.
How similar studies have gone: Prior evidence suggests nerve decompression and neuromodulation can relieve neuropathic pain in selected patients, but this exact combination in PDPN is less established and largely relies on observational data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients diagnosed with DPN who underwent lower extremity peripheral nerve decompression combined with PNS lead implantation in the Department of Neurosurgery of four hospitals (Qilu Hospital of Shandong University, Tangdu Hospital of Air Force Military Medical University, Army Medical Center of Army Medical University (Daping Hospital), and the First People's Hospital of Hangzhou Affiliated to Westlake University) between January 1, 2025 and May 31, 2026. 2. Patients with a confirmed diagnosis of diabetic peripheral neuropathy with pain as the predominant symptom. 3. Patients receiving lower extremity peripheral nerve decompression combined with PNS lead implantation for the first time. 4. Patients with complete electronic medical record data. Exclusion Criteria: 1. Patients who have previously undergone lower extremity peripheral nerve decompression surgery. 2. Patients with severe comorbidities, including severe cardiac disease, hepatic or renal insufficiency, and immune system deficiency. 3. Patients with substantial missing data.
Where it's running
-
Qilu hospital
Jinan, Shandong, China Recruiting -
Department of Neurosurgery, Tang-Du Hospital
Xi’an, Shanxi, China Recruiting -
Department of Neurosurgery, Hangzhou First People's Hospital
Hangzhou, Zhejiang, China Recruiting -
Department of Neurosurgery,Daping Hospital of Army Medical University
Chongqing, China Recruiting
Study contacts
- Principal investigator: Ning Yang, doctor — Department of Neurosurgery, Qilu Hospital of Shandong University
- Study coordinator: Ning Yang, doctor
- Email: yangning@sdu.edu.cn
- Phone: +86 18560088290
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cardio-Metabolic Clinic care for adults with type 2 diabetes and cardiovascular disease
This trial tests whether a specialized Cardio-Metabolic Clinic can improve heart function and overall health for adults with type 2 diabetes and cardiovascular disease compared with usual care.
-
Ceylon Cinnamon for blood sugar, lipids, BMI, and pain in painful diabetic neuropathy
This trial tests whether taking Ceylon cinnamon twice daily for six months helps adults with painful diabetic peripheral neuropathy improve their blood sugar, cholesterol, BMI, and pain.
-
Leg vs Arm Ergometer Exercise for Gestational Diabetes
This study tests whether leg-ergometer exercise helps control blood sugar and reduce stress more than arm-ergometer exercise in pregnant people with gestational diabetes.
-
Detecting heart muscle injury during below-knee leg surgery with peripheral nerve block
This will test whether measuring high‑sensitive troponin I during and after below‑knee leg surgery can detect heart muscle damage in adults receiving peripheral nerve blocks.
-
Comparing high-frequency spinal cord stimulation to traditional methods for diabetic nerve pain
This study tests if high-frequency spinal cord stimulation can help people with painful diabetic nerve pain more effectively than traditional methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.